Hengrui Medicine: Profitability Up, Successful Transition To "Innovation"
This article was originally published in PharmAsia News
Executive Summary
Having completed the transition from "imitation" to "innovation," Hengrui Medicine is expected to maintain strong growth due to rapidly increasing domestic sales of anticancer and surgical drugs